Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-266

I am waiting for the scientists to do what they must do, when they must do it. I believe Remestemcel-L will prove effective, and of course am hoping for overwhelming efficacy at the 60 percent readout. Not just for my investment, but because people who are dying might be saved.

I am not trying to argue science with you. I am simply saying that your complete lack of sensitivity toward the people who are dying, and those who love them, is appalling. And it isn't just people with Covid who are dying. It is people receiving substandard medical care because of overflowing hospitals, and millions of people who may starve because of the worldwide economic fallout.

As for the rationality of hope: It isn't just the 12 person compassionate use trial that gives me hope. It is the positive results of so many different cell therapy trials that you can read about in the cell therapy news thread.

From an investment standpoint, I encourage caution. I am the poster child for what can happen when you place large bets based on hope. But from a humanitarian perspective, I encourage hope.